Renal cell carcinoma treatment: The search for the right strategy
Poster Session 58
-
Location:Room 7, Capital suite (level 3)
-
Chairs:
-
Aims and objectives of this session To discuss various aspects which impact the indication for RCC therapy.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Institutes: University of Pennsylvania, Perelman School of Medicine, Division of Urology, Dept. of Surgery, Philadelphia, United States of America
Institutes: 1IRCCS San Raffaele, Dept. of Urology, Division of Oncology/Unit of Urology, URI, Milan, Italy, 2IRCCS San Raffaele, Dept. of Cardiology, Milan, Italy
Institutes: 1Moores Cancer Center, Dept. of Urology, La Jolla, United States of America, 2Spectrum Health, Dept. of Urology, Grand Rapids, United States of America, 3San Raffaele Scientific Institute, Dept. of Urology, Milan, Italy
Institutes: 1San Luigi Hospital, Dept. of Urology, Turin, Italy, 2San Luigi Hospital, Dept. of Nuclear Medicine, Turin, Italy, 3San Luigi Hospital, Dept. of Radiology, Turin, Italy
Institutes: 1King’s College London, Dept. of Cancer Imaging, London, United Kingdom, 2Siemens Healthineers, Dept. of MR Research Collaborations, Frimley, United Kingdom, 3Guy’s and St Thomas’ NHS Foundation Trust, Dept. of Radiology, London, United Kingdom, 4Guy’s and St Thomas’ NHS Foundation Trust, Dept. of Urology, London, United Kingdom, 5King’s College London, Dept. of Biomedical Engineering, London, United Kingdom, 6Guy’s and St Thomas’ NHS Foundation Trust, Dept. of Pathology, London, United Kingdom
Institutes: 1Fox Chase Cancer Center, Dept. of Urology, Philadelphia, United States of America, 2Vanderbilt University, Dept. of Biomedical Engineering, Nashville, United States of America, 3Assaf Harofe Medical Center, Dept. of Urology, Be’er Ya’akov, Israel, 4Temple University, Dept. of Biomedical Engineering, Philadelphia, United States of America
Institutes: 1Netherlands Cancer Institute, Dept. of Urology, Amsterdam, The Netherlands, 2Netherlands Cancer Institute, Dept. of Nuclear Medicine, Amsterdam, The Netherlands, 3Netherlands Cancer Institute, Dept. of Radiology, Amsterdam, The Netherlands
Institutes: 1IRCCS San Raffaele, Dept. of Urology, Division of Oncology, Milan, Italy, 2University Hospital Maggiore Della Carità, University of Piemonte Orientale, Dept. of Urology, Novara, Italy, 3IRCCS San Raffaele, Dept. of Pathology, Milan, Italy
Institutes: 1Rhode Island Hospital And The Miriam Hospital, Dept. of Urology, Providence, United States of America, 2University of Illinois, Dept. of Urology, Chicago, United States of America, 3Mayo Clinic, Dept. of Urology, Rochester, United States of America, 4Mayo Clinic, Health Sciences Research, Rochester, United States of America, 5Mayo Clinic, Dept. of Oncology, Rochester, United States of America, 6Mayo Clinic, Dept. of Pathology, Rochester, United States of America
Institutes: E. Wolfson M. C., Dept. of Urologic Surgery, Holon, Israel